| | | We ended up with the same number of portfolios, but with some changes in the participants. Also, in terms of foreign investments you’ve become much more cautious. This year only one participant went to an offshore exchange, with two picks on the Australian stock exchange (.AX).
Also compared to 2023, we ended up with the same number of distinct selections. But the number of shared selections is down, meaning that the popularity of the shared selections was higher.
PLEASE DOUBLECHECK THIS LIST. I can’t swear that every ticker leads to a biotech company (some of the names are pretty opaque), so make sure that these are the companies you desired.
The initial share prices, and numbers of shares purchased is coming shortly, and of course the first week’s results as well.
The participant list:
Player
| Number of Selections
| ALONER
| 8
| ARTHER RADLEY
| 8
| BULBAMAN
| 8
| DART LANZAR
| 10
| DEW_DILIGENCE
| 8
| ERIKOTTO
| 9
| JACK HARTMANN
| 10
| JR_95
| 10
| KATHLEEN
| 10
| NOTABOT
| 9
| RAJU_BIJLEE
| 10
| STEVE LOKNESS
| 10
| TECHNETIUM
| 8
| TOMATO
| 9
| TRACE I11
| 9
|
And their chosen portfolios (with allocations).
Player
| Stock
|
| Allocation
| ALONER
| ACRS
| Aclaris Therapeutics, Inc.
| 5.00%
| ALONER
| AFMD
| Affimed N.V.
| 20.00%
| ALONER
| CDTX
| Cidara Therapeutics, Inc.
| 20.00%
| ALONER
| CLSD
| Cellectar Biosciences, Inc.
| 5.00%
| ALONER
| CRVS
| Corvus Pharmaceuticals, Inc.
| 20.00%
| ALONER
| KZIA
| Kazia Therapeutics Limited
| 20.00%
| ALONER
| MRNA
| Moderna, Inc.
| 5.00%
| ALONER
| TWST
| Twist Bioscience Corporation
| 5.00%
| ARTHER RADLEY
| AKYA
| Akoya Biosciences, Inc.
| 15.00%
| ARTHER RADLEY
| EOLS
| Evolus, Inc.
| 10.00%
| ARTHER RADLEY
| EYEN
| Eyenovia, Inc.
| 20.00%
| ARTHER RADLEY
| KALV
| KalVista Pharmaceuticals, Inc.
| 20.00%
| ARTHER RADLEY
| LQDA
| Liquidia Corporation
| 10.00%
| ARTHER RADLEY
| OABI
| OmniAb, Inc.
| 5.00%
| ARTHER RADLEY
| STTK
| Shattuck Labs, Inc.
| 10.00%
| ARTHER RADLEY
| ZYXI
| Zynex, Inc.
| 10.00%
| BULBAMAN
| CU6.AX
| Clarity Pharmaceuticals Ltd
| 20.00%
| BULBAMAN
| CYTH
| Cyclo Therapeutics, Inc.
| 10.00%
| BULBAMAN
| LRMR
| Larimar Therapeutics, Inc.
| 10.00%
| BULBAMAN
| PMN
| ProMIS Neurosciences, Inc.
| 10.00%
| BULBAMAN
| SNGX
| Soligenix, Inc.
| 10.00%
| BULBAMAN
| TCON
| TRACON Pharmaceuticals, Inc.
| 10.00%
| BULBAMAN
| TLX.AX
| Telix Pharmaceuticals Limited
| 15.00%
| BULBAMAN
| VKTX
| Viking Therapeutics, Inc.
| 15.00%
| DART LANZAR
| BLUE
| bluebird bio, Inc.
| 10.00%
| DART LANZAR
| CRIS
| Curis, Inc.
| 10.00%
| DART LANZAR
| GRTS
| Gritstone bio, Inc.
| 10.00%
| DART LANZAR
| HALO
| Halozyme Therapeutics, Inc.
| 10.00%
| DART LANZAR
| IMCR
| Immunocore Holdings plc
| 10.00%
| DART LANZAR
| LEAP
| Leap Therapeutics, Inc.
| 10.00%
| DART LANZAR
| LQDA
| Liquidia Corporation
| 10.00%
| DART LANZAR
| MRNA
| Moderna, Inc.
| 10.00%
| DART LANZAR
| NBIX
| Neurocrine Biosciences, Inc.
| 10.00%
| DART LANZAR
| TMDX
| TransMedics Group, Inc.
| 10.00%
| DEW_DILIGENCE
| AVIR
| Atea Pharmaceuticals, Inc.
| 5.00%
| DEW_DILIGENCE
| BNTX
| BioNTech SE
| 5.00%
| DEW_DILIGENCE
| ENTA
| Enanta Pharmaceuticals, Inc.
| 20.00%
| DEW_DILIGENCE
| FRLN
| Freeline Therapeutics Holdings plc
| 20.00%
| DEW_DILIGENCE
| MRNA
| Moderna, Inc.
| 5.00%
| DEW_DILIGENCE
| RVNC
| Revance Therapeutics, Inc.
| 20.00%
| DEW_DILIGENCE
| VIR
| Vir Biotechnology, Inc.
| 20.00%
| DEW_DILIGENCE
| VKTX
| Viking Therapeutics, Inc.
| 5.00%
| ERIKOTTO
| GLTO
| Galecto, Inc.
| 10.00%
| ERIKOTTO
| INSM
| Insmed Incorporated
| 10.00%
| ERIKOTTO
| LIFE
| aTyr Pharma, Inc.
| 15.00%
| ERIKOTTO
| LRMR
| Larimar Therapeutics, Inc.
| 15.00%
| ERIKOTTO
| OCUL
| Ocular Therapeutix, Inc.
| 15.00%
| ERIKOTTO
| PYXS
| Pyxis Oncology, Inc.
| 5.00%
| ERIKOTTO
| SERA
| Sera Prognostics, Inc.
| 5.00%
| ERIKOTTO
| TNYA
| Tenaya Therapeutics, Inc.
| 10.00%
| ERIKOTTO
| TPST
| Tempest Therapeutics, Inc.
| 15.00%
| JACK HARTMANN
| APGE
| Apogee Therapeutics, Inc.
| 10.00%
| JACK HARTMANN
| ARWR
| Arrowhead Pharmaceuticals, Inc.
| 10.00%
| JACK HARTMANN
| AUPH
| Aurinia Pharmaceuticals Inc.
| 10.00%
| JACK HARTMANN
| BNTX
| BioNTech SE
| 10.00%
| JACK HARTMANN
| BRNS
| Barinthus Biotherapeutics plc
| 10.00%
| JACK HARTMANN
| CMPS
| COMPASS Pathways plc
| 10.00%
| JACK HARTMANN
| MRNA
| Moderna, Inc.
| 10.00%
| JACK HARTMANN
| NVCR
| NovoCure Limited
| 10.00%
| JACK HARTMANN
| PFE
| Pfizer Inc.
| 10.00%
| JACK HARTMANN
| SYRE
| Spyre Therapeutics, Inc.
| 10.00%
| JR_95
| AMLX
| Amylyx Pharmaceuticals, Inc.
| 10.00%
| JR_95
| ARWR
| Arrowhead Pharmaceuticals, Inc.
| 10.00%
| JR_95
| BGNE
| BeiGene, Ltd.
| 10.00%
| JR_95
| CLRB
| Cellectar Biosciences, Inc.
| 10.00%
| JR_95
| GLYC
| GlycoMimetics, Inc.
| 10.00%
| JR_95
| LIFE
| aTyr Pharma, Inc.
| 10.00%
| JR_95
| OCUL
| Ocular Therapeutix, Inc.
| 10.00%
| JR_95
| URGN
| UroGen Pharma Ltd.
| 10.00%
| JR_95
| VYNE
| VYNE Therapeutics Inc.
| 10.00%
| JR_95
| ZLAB
| Zai Lab Limited
| 10.00%
| KATHLEEN
| CNSP
| CNS Pharmaceuticals, Inc.
| 10.00%
| KATHLEEN
| CRVS
| Corvus Pharmaceuticals, Inc.
| 10.00%
| KATHLEEN
| ITRM
| Iterum Therapeutics plc
| 10.00%
| KATHLEEN
| LXRX
| Lexicon Pharmaceuticals, Inc.
| 10.00%
| KATHLEEN
| ONVO
| Organovo Holdings, Inc.
| 10.00%
| KATHLEEN
| PSTV
| Plus Therapeutics, Inc.
| 10.00%
| KATHLEEN
| SCYX
| SCYNEXIS, Inc.
| 10.00%
| KATHLEEN
| SLDB
| Solid Biosciences Inc.
| 10.00%
| KATHLEEN
| VERU
| Veru Inc.
| 10.00%
| KATHLEEN
| VERV
| Verve Therapeutics, Inc.
| 10.00%
| NOTABOT
| AMGN
| Amgen Inc.
| 11.11%
| NOTABOT
| BNTX
| BioNTech SE
| 11.11%
| NOTABOT
| CRSP
| CRISPR Therapeutics AG
| 11.11%
| NOTABOT
| EDIT
| Editas Medicine, Inc.
| 11.11%
| NOTABOT
| GILD
| Gilead Sciences, Inc.
| 11.11%
| NOTABOT
| IONS
| Ionis Pharmaceuticals, Inc.
| 11.11%
| NOTABOT
| MRNA
| Moderna, Inc.
| 11.11%
| NOTABOT
| REGN
| Regeneron Pharmaceuticals, Inc.
| 11.11%
| NOTABOT
| VRTX
| Vertex Pharmaceuticals Incorporated
| 11.11%
| RAJU_BIJLEE
| ALLO
| Allogene Therapeutics, Inc.
| 10.00%
| RAJU_BIJLEE
| ALT
| Altimmune, Inc.
| 10.00%
| RAJU_BIJLEE
| ARDX
| Ardelyx, Inc.
| 10.00%
| RAJU_BIJLEE
| CBUS
| Cibus, Inc.
| 10.00%
| RAJU_BIJLEE
| GLYC
| GlycoMimetics, Inc.
| 10.00%
| RAJU_BIJLEE
| IMTX
| Immatics N.V.
| 10.00%
| RAJU_BIJLEE
| IOVA
| Iovance Biotherapeutics, Inc.
| 10.00%
| RAJU_BIJLEE
| OCUL
| Ocular Therapeutix, Inc.
| 10.00%
| RAJU_BIJLEE
| RVNC
| Revance Therapeutics, Inc.
| 10.00%
| RAJU_BIJLEE
| VKTX
| Viking Therapeutics, Inc.
| 10.00%
| STEVE LOKNESS
| BEAM
| Beam Therapeutics Inc.
| 10.00%
| STEVE LOKNESS
| DSGN
| Design Therapeutics, Inc.
| 10.00%
| STEVE LOKNESS
| EXAI
| Exscientia plc
| 10.00%
| STEVE LOKNESS
| FHTX
| Foghorn Therapeutics Inc.
| 10.00%
| STEVE LOKNESS
| NTLA
| Intellia Therapeutics, Inc.
| 10.00%
| STEVE LOKNESS
| SCYX
| SCYNEXIS, Inc.
| 10.00%
| STEVE LOKNESS
| SEER
| Seer, Inc.
| 10.00%
| STEVE LOKNESS
| SLGC
| SomaLogic, Inc.
| 10.00%
| STEVE LOKNESS
| SPRO
| Spero Therapeutics, Inc.
| 10.00%
| STEVE LOKNESS
| STRO
| Sutro Biopharma, Inc.
| 10.00%
| TECHNETIUM
| ALT
| Altimmune, Inc.
| 12.50%
| TECHNETIUM
| AMLX
| Amylyx Pharmaceuticals, Inc.
| 12.50%
| TECHNETIUM
| IOVA
| Iovance Biotherapeutics, Inc.
| 12.50%
| TECHNETIUM
| NERV
| Minerva Neurosciences, Inc.
| 12.50%
| TECHNETIUM
| RVNC
| Revance Therapeutics, Inc.
| 12.50%
| TECHNETIUM
| TMO
| Thermo Fisher Scientific Inc.
| 12.50%
| TECHNETIUM
| VKTX
| Viking Therapeutics, Inc.
| 12.50%
| TECHNETIUM
| VRTX
| Vertex Pharmaceuticals Incorporated
| 12.50%
| TOMATO
| BTAI
| BioXcel Therapeutics, Inc.
| 10.00%
| TOMATO
| CCCC
| C4 Therapeutics
| 10.00%
| TOMATO
| HROW
| Harrow, Inc.
| 20.00%
| TOMATO
| NVAX
| Novavax, Inc.
| 10.00%
| TOMATO
| NVCT
| Nuvectis Pharma, Inc.
| 10.00%
| TOMATO
| OCUL
| Ocular Therapeutix, Inc.
| 10.00%
| TOMATO
| TARA
| Protara Therapeutics, Inc.
| 10.00%
| TOMATO
| TCON
| TRACON Pharmaceuticals, Inc.
| 10.00%
| TOMATO
| TERN
| Terns Pharmaceuticals, Inc.
| 10.00%
| TRACE I11
| ALNY
| Alnylam Pharmaceuticals, Inc.
| 5.00%
| TRACE I11
| ARGX
| argenx SE
| 10.00%
| TRACE I11
| CYTK
| Cytokinetics, Incorporated
| 10.00%
| TRACE I11
| GTHX
| G1 Therapeutics, Inc.
| 20.00%
| TRACE I11
| KRYS
| Krystal Biotech, Inc.
| 15.00%
| TRACE I11
| RARE
| Ultragenyx Pharmaceutical Inc.
| 5.00%
| TRACE I11
| REGN
| Regeneron Pharmaceuticals, Inc.
| 20.00%
| TRACE I11
| ROIV
| Roivant Sciences Ltd.
| 10.00%
| TRACE I11
| VINC
| Vincerx Pharma, Inc.
| 5.00%
|
|
|
